• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Nonalcoholic Steatohepatitis
Tags
  • Nonalcoholic Steatohepatitis (NASH)

 

Study title A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis
Disease or condition NASH-Nonalcoholic Steatohepatitis
Study type Interventional  (Clinical Trial)
Intervention/treatment Saroglitazar Magnesium or Placebo
Phase 2b
Study site Carolinas Medical Center, Center for Liver Disease and Transplant (Atrium Health)
Study location Charlotte, NC
Principal investigator name and email Andrew deLemos, andrew.delemos@atriumhealth.org
Study coordinator name and email Marina Sycheva, marina.sycheva@atriumhealth.org
Phone Contact 704-446-4835
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT05011305

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE